SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 166 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,624 | +24.8% | 456,219 | +79.9% | 0.31% | +34.6% |
| Q2 2023 | $5,308 | +192.3% | 253,631 | +195.0% | 0.23% | +168.6% |
| Q1 2023 | $1,816 | -8.3% | 85,971 | +10.5% | 0.09% | -21.8% |
| Q4 2022 | $1,980 | -99.8% | 77,780 | +59.1% | 0.11% | +54.9% |
| Q3 2022 | $1,175,000 | +11.6% | 48,900 | -10.6% | 0.07% | -10.1% |
| Q2 2022 | $1,053,000 | +45.8% | 54,714 | +31.7% | 0.08% | +68.1% |
| Q1 2022 | $722,000 | +4.5% | 41,534 | +31.5% | 0.05% | -45.3% |
| Q4 2021 | $691,000 | +222.9% | 31,586 | +230.7% | 0.09% | +26.5% |
| Q1 2021 | $214,000 | -65.1% | 9,550 | -65.4% | 0.07% | -61.1% |
| Q4 2020 | $613,000 | +117.4% | 27,570 | +44.1% | 0.18% | +94.4% |
| Q3 2020 | $282,000 | +76.2% | 19,130 | +77.5% | 0.09% | +66.7% |
| Q2 2020 | $160,000 | -35.5% | 10,780 | -52.3% | 0.05% | -48.6% |
| Q1 2020 | $248,000 | +10.2% | 22,580 | -11.7% | 0.10% | +56.7% |
| Q4 2019 | $225,000 | +71.8% | 25,580 | +46.4% | 0.07% | +36.7% |
| Q3 2019 | $131,000 | -11.5% | 17,470 | +10.1% | 0.05% | -10.9% |
| Q2 2019 | $148,000 | -71.3% | 15,870 | -78.4% | 0.06% | -48.6% |
| Q2 2018 | $516,000 | – | 73,499 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |